<- Go Home
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Market Cap
$10.1B
Volume
263.3K
Cash and Equivalents
$410.4M
EBITDA
$483.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.4B
Profit Margin
54.54%
52 Week High
$387.99
52 Week Low
$262.12
Dividend
N/A
Price / Book Value
1.35
Price / Earnings
-13.17
Price / Tangible Book Value
1.49
Enterprise Value
$9.9B
Enterprise Value / EBITDA
17.85
Operating Income
$333.9M
Return on Equity
9.79%
Return on Assets
1.85
Cash and Short Term Investments
$1.6B
Debt
$1.4B
Equity
$7.5B
Revenue
$2.6B
Unlevered FCF
$121.9M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium